Overview
- Description
The company develops innovative small molecule therapies targeting the tumor-stroma-immune interface to treat hard-to-treat cancers with minimal toxicity.
- Website
- Country
- The Netherlands
- Sector
- Health Biotechnology
*By clicking here you will be leaving the official EIC website and you will be directed to the Dealroom.co domain, an official EISMEA contractor for the EIC investor matchmaking platform.